Does TALQUETAMAB-TGVS Cause Ageusia? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Ageusia have been filed in association with TALQUETAMAB-TGVS. This represents 10.6% of all adverse event reports for TALQUETAMAB-TGVS.
88
Reports of Ageusia with TALQUETAMAB-TGVS
10.6%
of all TALQUETAMAB-TGVS reports
0
Deaths
15
Hospitalizations
How Dangerous Is Ageusia From TALQUETAMAB-TGVS?
Of the 88 reports, 15 (17.0%) required hospitalization.
Is Ageusia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TALQUETAMAB-TGVS. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does TALQUETAMAB-TGVS Cause?
Cytokine release syndrome (162)
Weight decreased (74)
Dysgeusia (73)
Skin exfoliation (65)
Immune effector cell-associated neurotoxicity syndrome (55)
Dry mouth (53)
Off label use (51)
Rash (48)
Onychomadesis (46)
Nail disorder (45)
What Other Drugs Cause Ageusia?
LENALIDOMIDE (1,473)
VISMODEGIB (958)
CABOZANTINIB S-MALATE (603)
SUNITINIB MALATE (473)
TERBINAFINE (397)
NIRMATRELVIR\RITONAVIR (354)
DUPILUMAB (311)
FLUTICASONE (293)
PALBOCICLIB (277)
ADALIMUMAB (259)
Which TALQUETAMAB-TGVS Alternatives Have Lower Ageusia Risk?
TALQUETAMAB-TGVS vs TAMIFLU
TALQUETAMAB-TGVS vs TAMOXIFEN
TALQUETAMAB-TGVS vs TAMSULOSIN
TALQUETAMAB-TGVS vs TAPENTADOL
TALQUETAMAB-TGVS vs TAPINAROF